|Multiple plasma biomarkers for risk stratification in patients with heart failure and preserved ejection fraction|
JA Chirinos, A Orlenko, L Zhao, MD Basso, ME Cvijic, Z Li, TE Spires, ...
Journal of the American College of Cardiology 75 (11), 1281-1295, 2020
|Model selection for metabolomics: predicting diagnosis of coronary artery disease using automated machine learning|
A Orlenko, D Kofink, LP Lyytikäinen, K Nikus, P Mishra, P Kuukasjärvi, ...
Bioinformatics 36 (6), 1772-1778, 2020
|Considerations for automated machine learning in clinical metabolic profiling: Altered homocysteine plasma concentration associated with metformin exposure.|
A Orlenko, JH Moore, P Orzechowski, RS Olson, J Cairns, PJ Caraballo, ...
Pacific Symposium on Biocomputing 2018 23, 460-471, 2018
|Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill children|
C Diorio, PA Shaw, E Pequignot, A Orlenko, F Chen, R Aplenc, DM Barrett, ...
Blood advances 4 (20), 5174-5183, 2020
|A comparison of methods for interpreting random forest models of genetic association in the presence of non-additive interactions|
A Orlenko, JH Moore
BioData mining 14 (1), 1-17, 2021
|Metabolomics Insights in Early Childhood Caries|
LH Heimisdottir, BM Lin, H Cho, A Orlenko, AA Ribeiro, A Simon-Soro, ...
Journal of Dental Research, 0022034520982963, 2021
|Selection on metabolic pathway function in the presence of mutation-selection-drift balance leads to rate-limiting steps that are not evolutionarily stable|
A Orlenko, AI Teufel, PB Chi, DA Liberles
Biology direct 11 (1), 1-14, 2016
|Flux control in glycolysis varies across the tree of life|
A Orlenko, RA Hermansen, DA Liberles
Journal of molecular evolution 82 (2), 146-161, 2016
|Plasma biomarkers associated with adverse outcomes in patients with calcific aortic stenosis|
MK Vidula, A Orlenko, L Zhao, L Salvador, AM Small, E Horton, JB Cohen, ...
European Journal of Heart Failure 23 (12), 2021-2032, 2021
|Characterizing the roles of changing population size and selection on the evolution of flux control in metabolic pathways|
A Orlenko, PB Chi, DA Liberles
BMC evolutionary biology 17 (1), 1-16, 2017
|Pathobiont-mediated spatial structuring enhances biofilm virulence in childhood oral disease|
H Cho, Z Ren, K Divaris, J Roach, B Lin, C Lin, A Azcarate-Peril, ...
|PLASMA BIOMARKERS FOR RISK STRATIFICATION OF OUTCOMES IN PATIENTS WITH AORTIC STENOSIS|
M Vidula, A Orlenko, L Zhao, L Salvador, A Smalll, E Horton, J Cohen, ...
Journal of the American College of Cardiology 77 (18_Supplement_1), 1753-1753, 2021
|A Targeted Plasma Multi-Marker Approach With Machine Learning for Risk Stratification in HFpEF: The TOPCAT Trial|
JA Chirinos, A Orlenko, L Zhao, M Basso, ME Cvijic, Z Li, T Spires, ...
Circulation 140 (Suppl_1), A14549-A14549, 2019
|How Do Pathways Evolve?: Mutation-selection Balance an Co-evolution in Metabolic Pathways|
University of Wyoming, 2016